glp 1 pill fda approved approves Eli Lilly's new weight loss Foundayo FDA approves Wegovy pill for

Lorcaserin, a serotonin 2C agonist approved in 2012, was initially considered safe

Male-pattern hair loss (androgenic alopecia) is already common and may accelerate during GLP-1 therapy due to shifting androgen metabolism

It is elevated in all forms of liver disease and functionally increased due to alcoholism and/or sluggish gallbladder or gallstone obstruction

For best acceptance, mix well with a low-NSC carrier such as soaked beet pulp or hay pellets, and introduce gradually over 710 days for selective eaters

Next-Generation Oral GLP-1 Medicines Research is now focused on developing new oral GLP-1 medicines that aim to: Remove the need for injections Improve convenience Reduce common side effects like nausea As outlined in the Zydus project document, novel oral GLP-1 candidates are being developed to make long-term treatment easier and more patient-friendly, especially for people hesitant about injections